Daminozide
Daminozide is listed in Annex II as a prohibited substance for cosmetic products placed on the EU market.
Chemical identity and properties
- IUPAC name
- 4-(2,2-dimethylhydrazinyl)-4-oxobutanoic acid
- Molecular formula
- C6H12N2O3
- Molecular weight
- 160.17 g/mol
- Exact mass
- 160.08479225 Da
- XLogP3
- -3.1
- Topological polar surface area
- 69.6 Ų
- Hydrogen-bond donors
- 2
- Hydrogen-bond acceptors
- 4
- Covalent units
- 1
- Defined stereocentres
- 0
Also known as
16 more reported names
External database identifiers
- ChEBI:CHEBI:4312
- ChEMBL:CHEMBL2164243
- EPA DTXSID:DTXSID9020370
- PubMed:38851594
- PubMed:22724510
- PubMed:22654586
- PubMed:22320078
- PubMed:22016636
- PubMed:21933378
- PubMed:21918607
- PubMed:21077902
- PubMed:20720197
- PubMed:20163890
- PubMed:17362413
- PubMed:16621501
Retrieved from NIH PubChem on 2026-08-31 by checksum-valid CAS matching. Chemical properties do not replace the regulatory decision on this page.
Record details
Chemical name
Daminozide
Regulatory information
SCCS opinions
- Opinion concerning Chemical Ingredients in Cosmetic Products classified as Carcinogenic, Mutagenic or Toxic to Reproduction according to the Chemicals Directive 67/548/EECC
- Opinion concerning Chemical Ingredients in Cosmetic Products classified as Carcinogenic, Mutagenic or Toxic to Reproduction according to the Chemicals Directive 67/548/EEC
Key data
Related records for Daminozide
Direct matches are limited for this record, so nearby entries from Annex II are shown as well.
Morpholine-4-carbonyl chloride
UVCB condensation product of: tetrakis-hydroxymethylphosphonium chloride, urea and distilled hydrog…
2-ethylhexanoic acid and its salts with the exception of those specified elsewhere in Annex VI to R…
4-hydroxy-3,5-diiodobenzonitrile [1]; 4-Cyano-2,6-diiodophenyl octanoate [2]
Bromoxynil (ISO) 3,5-Dibromo-4-hydroxybenzonitrile [1] and Bromoxynil heptanoate (ISO) [2]
2,6-Dibromo-4-cyanophenyl octanoate
5-Chloro-1,3-dihydro-2H-indol-2-one
What Annex II means for Daminozide
Daminozide is listed as a prohibited substance under Annex II of EU Cosmetics Regulation 1223/2009 and must not be intentionally added. Article 17 separately addresses unintended small quantities that are technically unavoidable under good manufacturing practice and compatible with the Article 3 safety requirement.
Formulators must screen their ingredients and raw materials to ensure none contain this substance. Suppliers should provide documentation confirming absence when requested.
The page also surfaces 12 related annex records with overlapping identifiers, annex logic or naming patterns.
Compliance checklist
- Verify this substance is absent from all raw materials and finished formulations.
- Request absence confirmation or CoA from raw material suppliers.
- Document the screening result in the Product Information File (PIF).
Frequently asked questions
Source note for Annex II record Daminozide
This page summarizes one Annex II record for Daminozide from public European Commission cosmetic materials and adds linked inventory or identifier matches when available.
Use this record page to review Annex II conditions for Daminozide, but confirm any final regulatory decision against the current official annex wording and source files.
Tools & next steps
Check your formula
Paste a full INCI list to detect Daminozide and other flagged EU annex records in one pass.
INCI CheckerCompare entries
Compare Daminozide side by side with another annex record to review differences in restrictions, concentrations and annex placement.
CompareBrowse the annex
See all records in Annex II and compare regulatory conditions across substances in this annex.
Open Annex II